These findings are consistent with prior work by our group and others, finding significant delays along the continuum of BC care in SSA.6,11-13,23,27 Compared with studies from the US, women in the SABCHO cohort were almost twice as likely to experience treatment delays of >90 days (19.5% vs 10% or less in studies analyzing BC patients from the SEER-Medicare database).16,28 Regression analysis revealed that relative to CHBAH, patients at ALH, GH, and NH had longer treatment delays, as did those living further away from a treatment hospital and those who had ER/PR positive BC. The gene discussed is PGR; the disease is breast cancer.